Table 1 Clinical and pathological features of 57 patients diagnosed with PFTC (2006–2015)
Characteristics | No. Patients | % |
|---|---|---|
Age | Â | Â |
> 60 | 37 | 65% |
≤ 60 | 20 | 35% |
Menopause at diagnosis | Â | Â |
Yes | 34 | 60% |
No | 23 | 40% |
Nulliparous | Â | Â |
Yes | 3 | 5% |
No | 54 | 95% |
Main clinical manifestation | Â | Â |
Latzko triad symptom | 5 | 9% |
Vaginal bleeding / discharge | 35 | 61% |
Abdominal pain | 5 | 9% |
Pelvic mass | 9 | 16% |
Others | 3 | 5% |
Preoperative diagnosis | Â | Â |
FTC/Adnexal mass | 29 | 51% |
Ovarian malignancy | 20 | 35% |
Uterine malignacy | 2 | 4% |
Cervical cancer | 1 | 2% |
benign tumor | 5 | 9% |
Histological subtype | Â | Â |
High grade serous | 48 | 84% |
Mucinous | 1 | 2% |
Endometrioid | 4 | 7% |
Clear cell | 2 | 4% |
Sarcomatoid | 1 | 2% |
Mixed | 1 | 2% |
FIGO Stage | Â | Â |
I | 26 | 46% |
II | 15 | 26% |
III | 16 | 28% |
Grade | Â | Â |
I | 1 | 2% |
II | 2 | 3% |
III | 51 | 90% |
unkown | 3 | 5% |
Preoperative serum CA 125, U/mL | Â | Â |
≥ 35 | 35 | 61% |
< 35 | 22 | 39% |